These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3245972)

  • 1. Enzymatic synthesis of cholecystokinin-octapeptide.
    Sakina K; Kawazura K; Morihara K; Yajima H
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):3915-9. PubMed ID: 3245972
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and analgesic activity of cholecystokinin-heptapeptide analogs with N-terminal substitution.
    Iuchi K; Nitta M; Ito K; Morimoto Y; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):959-65. PubMed ID: 3409413
    [No Abstract]   [Full Text] [Related]  

  • 3. [Improved synthesis of the highly active cholecystokinin sequence succinyl Tyr (OSO3-)-Met-Gly-Trp-Asp-Phe-NH2].
    Henklein P; Penke B; Georgi M; Halatsch WR; Niedrich H; Ott T
    Pharmazie; 1987 Jun; 42(6):413-4. PubMed ID: 3671462
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrated process for the enzymatic synthesis of the octapeptide PhAcCCK-8.
    Fité M; Clapés P; López-Santín J; Benaiges MD; Caminal G
    Biotechnol Prog; 2002; 18(6):1214-20. PubMed ID: 12467454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of CCK-8 tetrapeptide fragment by enzymatic method.
    Xiang G; Eckstein H
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(3):234-5, 241. PubMed ID: 14526420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of tyrosine-O-[35S]sulfated cholecystokinin octapeptide from a nonsulfated precursor peptide.
    Nakahara T; Waki M; Uchimura H; Hirano M; Kim JS; Matsumoto T; Nakamura K; Ishibashi K; Hirano H; Shiraishi A
    Anal Biochem; 1986 Apr; 154(1):194-9. PubMed ID: 3706722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the C-terminal octapeptide of cholecystokinin with a high-specific-activity iodinated imidoester: preparation, characterization, and binding to isolated pancreatic acinar cells.
    Praissman M; Izzo RS; Berkowitz JM
    Anal Biochem; 1982 Mar; 121(1):190-8. PubMed ID: 6283943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synthesis of protected active peptide analogues of cholecystokinin and study of their biological activities].
    Guo L; Weng L
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):388-91. PubMed ID: 8150438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-catalyzed peptide bond formation: application to synthesis of the COOH-terminal octapeptide of cholecystokinin.
    Kullmann W
    Proc Natl Acad Sci U S A; 1982 May; 79(9):2840-4. PubMed ID: 6283547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholecystokinin octapeptide sulphate ester and unsulphated cholecystokinin octapeptide on active avoidance behaviour in rats.
    Fekete M; Bokor M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(1-2):57-63. PubMed ID: 6306996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of N alpha-hydroxysulfonyl-[Nle28,31]-CCK26-33.
    Sugg EE; Shook JE; Serra M; Korc M; Yamamura HI; Burks TF; Hruby VJ
    Life Sci; 1986 Nov; 39(18):1623-9. PubMed ID: 2430160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans.
    You CH; Rominger JM; Chey WY
    Gastroenterology; 1983 Jul; 85(1):40-5. PubMed ID: 6303892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin octapeptide stimulates phasic and tonic pyloric motility in healthy humans.
    Fraser R; Fone D; Horowitz M; Dent J
    Gut; 1993 Jan; 34(1):33-7. PubMed ID: 8432448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cholecystokinin receptor sites in guinea-pig cortical membranes using [125I]Bolton Hunter-cholecystokinin octapeptide.
    Lin CW; Miller T
    J Pharmacol Exp Ther; 1985 Mar; 232(3):775-80. PubMed ID: 2983069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of somatostatin on cholecystokinin octapeptide induced bile regurgitation under stress: ionic and molecular mechanisms.
    Si X; Huang L; Luo H; Shi R
    Regul Pept; 2009 Aug; 156(1-3):34-41. PubMed ID: 19445970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular forms of cholecystokinin in the brain and the relationship to neuronal gastrins.
    Rehfeld JF; Hansen HF; Marley PD; Stengaard-Pedersen K
    Ann N Y Acad Sci; 1985; 448():11-23. PubMed ID: 3896093
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T; Fekete M; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked prolongation in disappearance half-time of plasma cholecystokinin-octapeptide in patients with hepatic cirrhosis.
    Kanayama S; Himeno S; Kurokawa M; Shinomura Y; Kuroshima T; Okuno M; Tsuji K; Higashimoto Y; Ikei N; Hashimura E
    Am J Gastroenterol; 1985 Jul; 80(7):557-60. PubMed ID: 4014106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of gallbladder contraction using intramuscular sincalide.
    Rosenquist CJ; Barcia TC
    Radiology; 1983 Jan; 146(1):21-3. PubMed ID: 6294732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.